Literature DB >> 32942314

Direct Oral Anticoagulant Dosing in Extremes of Body Weight: Time to Revisit the Guidelines?

Arjun K Pandey1, John W Eikelboom2,3,4.   

Abstract

Year:  2020        PMID： 32942314     DOI： 10.1055/s-0040-1716753

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  2 in total

Review 1.  Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review.

Authors:  Stefano Ballestri; Elisa Romagnoli; Dimitriy Arioli; Valeria Coluccio; Alessandra Marrazzo; Afroditi Athanasiou; Maria Di Girolamo; Cinzia Cappi; Marco Marietta; Mariano Capitelli
Journal:  Adv Ther       Date:  2022-10-16       Impact factor: 4.070

2.  Evaluation of safety and efficacy outcomes of direct oral anticoagulants versus warfarin in normal and extreme body weights for the treatment of atrial fibrillation or venous thromboembolism.

Authors:  Alison R Novak; Courtney Shakowski; Toby C Trujillo; Garth C Wright; Scott W Mueller; Tyree H Kiser
Journal:  J Thromb Thrombolysis       Date:  2022-06-10       Impact factor: 5.221
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.